Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Conversation logo

Usually, World Immunisation Week is a chance for those of us who research vaccines to reinforce the message about their importance in saving lives. From whooping cough to polio, measles to meningitis, vaccines have quietly been saving millions of lives, every year, for decades.

Usually, nobody really cares or takes notice. However, 2021 is different. In this last year, we’ve heard a lot about public health science, from how diseases take root and are spread, to how new drug therapies – including vaccines – are developed, trialled and monitored for safety and impact after their rollout. People are aware that COVID-19 vaccines are saving lives – hundreds of thousands globally.

Normally, I’d want to join in celebrating this increased awareness of immunisation – outdoors in a group of six or less, of course. But despite our success developing COVID-19 vaccines, we need to confront a hard truth: globally, there aren’t enough doses in people’s arms. Nor are vaccines being spread widely enough across the world. Over 1 billion doses have been given in a matter of months, but still more than 90% of the world’s population haven’t been protected.

Read the full article on The Conversation website, written by Professor Andrew Pollard, Oxford Vaccine Group

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.